Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study. [electronic resource]
Producer: 19980622Description: 481-90 p. digitalISSN:- 0969-7128
- Adult
- Biolistics
- Cancer Vaccines
- Female
- Gene Transfer Techniques
- Genetic Therapy -- methods
- Humans
- Hypersensitivity, Delayed
- Immunohistochemistry
- Interleukin-10 -- metabolism
- Interleukin-12 -- genetics
- Killer Cells, Natural -- immunology
- Male
- Melanoma -- immunology
- Middle Aged
- Polymerase Chain Reaction
- T-Lymphocytes -- immunology
- Transforming Growth Factor beta -- metabolism
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.